Valiant Laboratories IPO Description – Incorporation in 2021, Valiant Laboratories is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company focusing on the manufacturing of Paracetamol. Bulk drugs/APIs serve as raw materials for manufacturing finished dosage forms or formulations.
Valiant Laboratories manufacturing facility is located at Palghar, in the state of Maharashtra, India which is spread over an aggregate parcel of land measuring about 2,000 sq. mts. with an aggregate annual total installed capacity of 9,000 MT per annum.
For the financial year ended 31 March 2023, 2022, and 2021, the revenue from sales outside India contributed 0.39%, 0.60 %, and 0.33 %, respectively of the total revenue from operations. The revenue from operations grew at a CAGR of 23.90% between FY 2017 and FY 2023. The restated profit after tax, grew at a CAGR of 26.81% between FY 2017 and FY 2023.
Promoters of Valiant Laboratories – Shantilal Shivji Vora and Dhanvallabh Ventures LLP
Valiant Laboratories IPO Details
| Valiant Laboratories IPO Dates | 27 Sep – 3 Oct 2023 |
| Valiant Laboratories IPO Price | INR 133 – 140 per share |
| Fresh issue | 10,890,000 shares INR 144.84 – 152.46 crore |
| Offer For Sale | NIL |
| Total IPO size | 10,890,000 shares INR 144.84 – 152.46 crore |
| Minimum bid (lot size) | 105 shares INR 14,700 |
| Face Value | INR 10 per share |
| Retail Allocation | 35% |
| Listing On | BSE, NSE |
Valiant Laboratories Financial Performance
| Â | FY 2021 | FY 2022 | FY 2023 |
| Revenue | 82.38 | 209.14 | 333.91 |
| Expenses | 72.04 | 179.73 | 300.64 |
| Net income | 4.75 | 22.59 | 29.03 |
| Margin (%) | 5.77 | 10.80 | 8.69 |
Valiant Laboratories Offer News
- Valiant Laboratories RHP
- Valiant Laboratories DRHP
- ASBA IPO Forms
- Live IPO Subscription Status
- IPO Subscription Status
Valiant Laboratories Valuations & Margins
| FY 2021 | FY 2022 | FY 2023 | |
| EPS | 10.83 | 9.52 | 8.91 |
| PE ratio | – | – | 14.93 – 15.71 |
| RONW (%) | 34.54 | 38.48 | 28.86 |
| NAV | – | – | 30.86 |
| ROCE (%) | 70.86 | 35.75 | 22.76 |
| EBITDA (%) | 27.42 | 14.52 | 10.51 |
| Debt/Equity | 0.00 | 0.85 | 0.59 |
Valiant Laboratories IPO GMP Today (Daily Trend)
| Date | Day-wise IPO GMP | Kostak | Subject to Sauda |
| 5 October 2023 | 25 | – | – |
| 4 October 2023 | 20 | – | – |
| 3 October 2023 | 15 | – | – |
| 2 October 2023 | 15 | – | – |
| 30 September 2023 | 15 | – | – |
| 29 September 2023 | 10 | – | – |
Valiant Laboratories IPO Subscription – Live Updates
| Category | QIB | NII | Retail | Total |
|---|---|---|---|---|
| Shares Offered | 21,78,030 | 16,33,500 | 38,11,500 | 76,23,030 |
| 3 Oct 2023 | 20.83 | 73.62 | 16.00 | 29.73 |
| 29 Sep 2023 | 1.05 | 6.28 | 4.56 | 3.93 |
| 28 Sep 2023 | 0.05 | 0.29 | 1.28 | 0.72 |
| 27 Sep 2023 | 0.00 | 0.11 | 0.62 | 0.33 |
Valiant Laboratories IPO Allotment Status
Valiant Laboratories IPO allotment is now available on Link Intime’s website. Click on this link to get allotment status.
Valiant Laboratories IPO Dates & Listing Performance
| Valiant Laboratories IPO Opening Date | 27 September 2023 |
| Valiant Laboratories IPO Closing Date | 3 October 2023 |
| Finalization of Basis of Allotment | 4 October 2023 |
| Initiation of refunds | 5 October 2023 |
| Transfer of shares to demat accounts | 5 October 2023 |
| Valiant Laboratories IPO Listing Date | 6 October 2023 |
| Opening Price on NSE | INR 162.15 per share (up 15.82%) |
| Closing Price on NSE | INR 170.25 per share (up 21.61%) |
Valiant Laboratories IPO Reviews – Subscribe or Avoid?
Angel One –
Anand Rathi –
Antique Stock Broking –
Arihant Capital –
Ashika Research –
Asit C Mehta –
BP Wealth – Subscribe
Canara Bank Securities – Avoid
Choice Broking –
Dalal & Broacha –
Elite Wealth – Aggressive Investors may Subscribe
GCL Broking –
Geojit –
GEPL Capital – Subscribe
Hem Securities –
ICICIdirect –
Jainam Broking –
KR Choksey –
LKP Research –
Marwadi Financial –
Motilal Oswal –
Nirmal Bang –
Reliance Securities –
Religare Broking –
Samco Securities –
SMC Global – 2/5
Swastika Investmart –
Ventura Securities – Not Rated
Valiant Laboratories Offer Lead Manager
UNISTONE CAPITAL PRIVATE LIMITED
A/305, Dynasty Business Park, Andheri Kurla Road,
Andheri East, Mumbai 400059, Maharashtra
Phone:+91 98200 57533
Email:Â [email protected]
Website:Â www.unistonecapital.com
Valiant Laboratories Offer Registrar
LINK INTIME INDIA PRIVATE LIMITED
C-101, 1st Floor, 247 Park
L.B.S. Marg, Vikhroli West
Mumbai – 400 083, Maharashtra
Phone:Â +91 22 4918 6200
Email:Â [email protected]
Website: www.linkintime.co.in
Valiant Laboratories Contact Details
VALIANT LABORATORIES LIMITED
104, Udyog Kshetra, Mulund Goregaon Link Road,
Mulund West, Mumbai- 400080, Maharashtra
Phone:Â +91-22-4971 2001
Email: [email protected]
Website: www.valiantlabs.in
Valiant Laboratories IPO FAQs
How many shares in Valiant Laboratories IPO are reserved for HNIs and retail investors?
The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%.
How to apply in Valiant Laboratories Public Offer?
The best way to apply in Valiant Laboratories public offer is through Internet banking ASBA (know all about ASBA here). You can also apply online through your stock broker using UPI. If you prefer to make paper applications, fill up an offline IPO form and deposit the same to your broker.
What is Valiant Laboratories IPO GMP today?
Valiant Laboratories IPO GMP today is INR 25 per share.
What is Valiant Laboratories kostak rate today?
Valiant Laboratories kostak rate today is INR NA per application.
What is Valiant Laboratories Subject to Sauda rate today?
Valiant Laboratories Subject to Sauda rate today is INR NA per application.
